Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2005 1
2006 1
2007 4
2009 1
2010 1
2011 5
2013 2
2014 1
2016 3
2017 1
2019 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia-Myo-inositoltrispyrophophate as model.
Grossmann R, Schneider MA, Linecker M, Lehn JM, Nicolau C, Traber M, Tay F, Vicente D, Jetter A, Mollet A, Szucs T, Graf R, Clavien PA, Limani P. Grossmann R, et al. Among authors: nicolau c. Pharmacol Res. 2020 Apr;154:104238. doi: 10.1016/j.phrs.2019.04.022. Epub 2019 Apr 19. Pharmacol Res. 2020. PMID: 31009662 Review. No abstract available.
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors.
Schneider MA, Linecker M, Fritsch R, Muehlematter UJ, Stocker D, Pestalozzi B, Samaras P, Jetter A, Kron P, Petrowsky H, Nicolau C, Lehn JM, Humar B, Graf R, Clavien PA, Limani P. Schneider MA, et al. Among authors: nicolau c. Nat Commun. 2021 Jun 21;12(1):3807. doi: 10.1038/s41467-021-24069-w. Nat Commun. 2021. PMID: 34155211 Free PMC article. Clinical Trial.
"Endothelial Antibody Factory" at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases.
Thinard R, Farkas AE, Halasa M, Chevalier M, Brodaczewska K, Majewska A, Zdanowski R, Paprocka M, Rossowska J, Duc LT, Greferath R, Krizbai I, Van Leuven F, Kieda C, Nicolau C. Thinard R, et al. Among authors: nicolau c. Pharmaceutics. 2022 Jul 6;14(7):1418. doi: 10.3390/pharmaceutics14071418. Pharmaceutics. 2022. PMID: 35890313 Free PMC article.
Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases.
Hickman DT, López-Deber MP, Ndao DM, Silva AB, Nand D, Pihlgren M, Giriens V, Madani R, St-Pierre A, Karastaneva H, Nagel-Steger L, Willbold D, Riesner D, Nicolau C, Baldus M, Pfeifer A, Muhs A. Hickman DT, et al. Among authors: nicolau c. J Biol Chem. 2011 Apr 22;286(16):13966-76. doi: 10.1074/jbc.M110.186338. Epub 2011 Feb 22. J Biol Chem. 2011. PMID: 21343310 Free PMC article.
Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate.
Limani P, Linecker M, Kachaylo E, Tschuor C, Kron P, Schlegel A, Ungethuem U, Jang JH, Georgiopoulou S, Nicolau C, Lehn JM, Graf R, Humar B, Clavien PA. Limani P, et al. Among authors: nicolau c. Clin Cancer Res. 2016 Dec 1;22(23):5887-5897. doi: 10.1158/1078-0432.CCR-15-3112. Epub 2016 Aug 3. Clin Cancer Res. 2016. PMID: 27489288 Free article.
27 results